The many faces of Pluripotency: In vitro adaptations of a continuum of in vivo states

BMC Developmental Biology

Volumn 17, Issue 1, 2017, Pages

  Morgani, Sophie ^a,b   Nichols, Jennifer ^b   Hadjantonakis, Anna Katerina ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Chimaera; Embryonic stem cells; Epiblast stem cells; Epiblast like cells; Formative; Ground state; Intermediate; Na ve; Pluripotency; Primed

Indexed keywords

ANIMAL; BLASTOCYST; CELL DIFFERENTIATION; CYTOLOGY; GASTRULATION; GERM LAYER; METABOLISM; PLURIPOTENT STEM CELL; SIGNAL TRANSDUCTION;

ANIMALS; BLASTOCYST; CELL DIFFERENTIATION; GASTRULATION; GERM LAYERS; PLURIPOTENT STEM CELLS; SIGNAL TRANSDUCTION;

EID: 85020746648     PISSN: None     EISSN: 1471213X     Source Type: Journal    
DOI: 10.1186/s12861-017-0150-4     Document Type: Review

References (207)

1. Arnold SJ, Robertson EJ. Making a commitment: cell lineage allocation and axis patterning in the early mouse embryo. Nat Rev Mol Cell Biol. 2009;10(2):91-103.
2. Nichols J, Smith A. Naive and primed pluripotent states. Cell Stem Cell. 2009;4(6):487-92.
3. Brons IG, et al. Derivation of pluripotent epiblast stem cells from mammalian embryos. Nature. 2007;448(7150):191-5.
4. Evans MJ, Kaufman MH. Establishment in culture of pluripotential cells from mouse embryos. Nature. 1981;292(5819):154-6.
5. Kaufman-Francis, K., et al., Differential response of epiblast stem cells to Nodal and Activin signalling: a paradigm of early endoderm development in the embryo. Philos Trans R Soc Lond B Biol Sci, 2014. 369(1657).
6. Tesar PJ. Derivation of germ-line-competent embryonic stem cell lines from preblastocyst mouse embryos. Proc Natl Acad Sci U S A. 2005;102(23):8239-44.
7. Doetschman TC, et al. The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. J Embryol Exp Morphol. 1985;87:27-45.
8. Keller GM. In vitro differentiation of embryonic stem cells. Curr Opin Cell Biol. 1995;7(6):862-9.
9. Leahy A, et al. Use of developmental marker genes to define temporal and spatial patterns of differentiation during embryoid body formation. J Exp Zool. 1999;284(1):67-81.
10. Beddington RS, Robertson EJ. An assessment of the developmental potential of embryonic stem cells in the midgestation mouse embryo. Development. 1989;105(4):733-7.
11. Huang Y, et al. In vivo differentiation potential of epiblast stem cells revealed by chimeric embryo formation. Cell Rep. 2012;2(6):1571-8.
12. Martin GR. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci U S A. 1981;78(12):7634-8.
13. Boroviak T, et al. The ability of inner-cell-mass cells to self-renew as embryonic stem cells is acquired following epiblast specification. Nat Cell Biol. 2014;16(6):516-28.
14. Brook FA, Gardner RL. The origin and efficient derivation of embryonic stem cells in the mouse. Proc Natl Acad Sci U S A. 1997;94(11):5709-12.
15. Delhaise F, et al. Establishment of an embryonic stem cell line from 8-cell stage mouse embryos. Eur J Morphol. 1996;34(4):237-43.
16. Guo G, et al. Klf4 reverts developmentally programmed restriction of ground state pluripotency. Development. 2009;136(7):1063-9.
17. Tesar PJ, et al. New cell lines from mouse epiblast share defining features with human embryonic stem cells. Nature. 2007;448(7150):196-9.
18. Bao S, et al. Epigenetic reversion of post-implantation epiblast to pluripotent embryonic stem cells. Nature. 2009;461(7268):1292-5.
19. Hanna J, et al. Metastable pluripotent states in NOD-mouse-derived ESCs. Cell Stem Cell. 2009;4(6):513-24.
20. Kim H, et al. Modulation of beta-catenin function maintains mouse epiblast stem cell and human embryonic stem cell self-renewal. Nat Commun. 2013;4:2403.
21. Bernemann C, et al. Distinct developmental ground states of epiblast stem cell lines determine different pluripotency features. Stem Cells. 2011;29(10):1496-503.
22. Greber B, et al. Conserved and divergent roles of FGF signaling in mouse epiblast stem cells and human embryonic stem cells. Cell Stem Cell. 2010;6(3):215-26.
23. Zhou H, et al. Conversion of mouse epiblast stem cells to an earlier pluripotency state by small molecules. J Biol Chem. 2010;285(39):29676-80.
24. Yang J, et al. Stat3 activation is limiting for reprogramming to ground state pluripotency. Cell Stem Cell. 2010;7(3):319-28.
25. Silva J, et al. Nanog is the gateway to the pluripotent ground state. Cell. 2009;138(4):722-37.
26. Guo G, Smith A. A genome-wide screen in EpiSCs identifies Nr5a nuclear receptors as potent inducers of ground state pluripotency. Development. 2010;137(19):3185-92.
27. Smith AG, et al. Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides. Nature. 1988;336(6200):688-90.
28. Williams RL, et al. Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells. Nature. 1988;336(6200):684-7.
29. Ying QL, et al. BMP induction of id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell. 2003;115(3):281-92.
30. Ohtsuka S, Nakai-Futatsugi Y, Niwa H. LIF signal in mouse embryonic stem cells. JAKSTAT. 2015;4(2):e1086520.
31. Morikawa M, et al. BMP sustains embryonic stem cell self-renewal through distinct functions of different Kruppel-like factors. Stem Cell Reports. 2016;6(1):64-73.
32. Conover JC, et al. Ciliary neurotrophic factor maintains the pluripotentiality of embryonic stem cells. Development. 1993;119(3):559-65.
33. Pennica D, et al. Cardiotrophin-1. Biological activities and binding to the leukemia inhibitory factor receptor/gp130 signaling complex. J Biol Chem. 1995;270(18):10915-22.
34. Rose TM, et al. Oncostatin M (OSM) inhibits the differentiation of pluripotent embryonic stem cells in vitro. Cytokine. 1994;6(1):48-54.
35. Wolf E, et al. Efficient generation of chimaeric mice using embryonic stem cells after long-term culture in the presence of ciliary neurotrophic factor. Transgenic Res. 1994;3(3):152-8.
36. Yoshida K, et al. Maintenance of the pluripotential phenotype of embryonic stem cells through direct activation of gp130 signalling pathways. Mech Dev. 1994;45(2):163-71.
37. Hirai H, Karian P, Kikyo N. Regulation of embryonic stem cell self-renewal and pluripotency by leukaemia inhibitory factor. Biochem J. 2011;438(1):11-23.
38. Li Z, et al. BMP4 signaling acts via dual-specificity phosphatase 9 to control ERK activity in mouse embryonic stem cells. Cell Stem Cell. 2012;10(2):171-82.
39. Qi X, et al. BMP4 supports self-renewal of embryonic stem cells by inhibiting mitogen-activated protein kinase pathways. Proc Natl Acad Sci U S A. 2004;101(16):6027-32.
40. Di-Gregorio A, et al. BMP signalling inhibits premature neural differentiation in the mouse embryo. Development. 2007;134(18):3359-69.
41. Ware CB, et al. Targeted disruption of the low-affinity leukemia inhibitory factor receptor gene causes placental, skeletal, neural and metabolic defects and results in perinatal death. Development. 1995;121(5):1283-99.
42. Takeda K, et al. Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc Natl Acad Sci U S A. 1997;94(8):3801-4.
43. Nichols J, et al. Physiological rationale for responsiveness of mouse embryonic stem cells to gp130 cytokines. Development. 2001;128(12):2333-9.
44. Li M, Sendtner M, Smith A. Essential function of LIF receptor in motor neurons. Nature. 1995;378(6558):724-7.
45. Do DV, et al. A genetic and developmental pathway from STAT3 to the OCT4-NANOG circuit is essential for maintenance of ICM lineages in vivo. Genes Dev. 2013;27(12):1378-90.
46. Martin Gonzalez J, et al. Embryonic stem cell culture conditions support distinct states associated with different developmental stages and potency. Stem Cell Reports. 2016;7(2):177-91.
47. Ahmed, K., et al., Global Chromatin Architecture Reflects Pluripotency and Lineage Commitment in the Early Mouse Embryo. PLoS One, 2010. 5(5).
48. Efroni S, et al. Global transcription in pluripotent embryonic stem cells. Cell Stem Cell. 2008;2(5):437-47.
49. Gaspar-Maia, A., et al., Open chromatin in pluripotency and reprogramming (vol 12, pg 36, 2011). Nat Rev Mol Cell Biol, 2011. 12(4).
50. Aoto T, et al. Nuclear and chromatin reorganization in the MHC-Oct3/4 locus at developmental phases of embryonic stem cell differentiation. Dev Biol. 2006;298(2):354-67.
51. Azuara V, et al. Chromatin signatures of pluripotent cell lines. Nat Cell Biol. 2006;8(5):532-8.
52. Meissner A, et al. Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature. 2008;454(7205):766-70.
53. Christophorou MA, et al. Citrullination regulates pluripotency and histone H1 binding to chromatin. Nature. 2014;507(7490):104-+.
54. Xiao S, et al. SMARCAD1 contributes to the regulation of naive Pluripotency by interacting with Histone Citrullination. Cell Rep. 2017;18(13):3117-28.
55. Williams LH, et al. Transcription precedes loss of Xist coating and depletion of H3K27me3 during X-chromosome reprogramming in the mouse inner cell mass. Development. 2011;138(10):2049-57.
56. Chen G, et al. Single-cell analyses of X chromosome inactivation dynamics and pluripotency during differentiation. Genome Res. 2016;26(10):1342-54.
57. Yeo JC, Ng HH. The transcriptional regulation of pluripotency. Cell Res. 2013;23(1):20-32.
58. Nichols J, Smith A. Pluripotency in the embryo and in culture. Cold Spring Harb Perspect Biol. 2012;4(8):a008128.
59. Yeom YI, et al. Germline regulatory element of Oct-4 specific for the totipotent cycle of embryonal cells. Development. 1996;122(3):881-94.
60. Houbaviy HB, Murray MF, Sharp PA. Embryonic stem cell-specific MicroRNAs. Dev Cell. 2003;5(2):351-8.
61. Marson A, et al. Connecting microRNA genes to the core transcriptional regulatory circuitry of embryonic stem cells. Cell. 2008;134(3):521-33.
62. Svoboda P, Flemr M. The role of miRNAs and endogenous siRNAs in maternal-to-zygotic reprogramming and the establishment of pluripotency. EMBO Rep. 2010;11(8):590-7.
63. Takahashi K, Yamanaka S. A decade of transcription factor-mediated reprogramming to pluripotency. Nat Rev Mol Cell Biol. 2016;17(3):183-93.
64. Anokye-Danso F, et al. Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to Pluripotency (vol 8, pg 376, 2011). Cell Stem Cell. 2012;11(6):53-853.
65. Judson RL, et al. Embryonic stem cell-specific microRNAs promote induced pluripotency. Nat Biotechnol. 2009;27(5):459-61.
66. Melton C, Judson RL, Blelloch R. Opposing microRNA families regulate self-renewal in mouse embryonic stem cells (vol 463, pg 621, 2010). Nature. 2010;464(7285):126.
67. Davenport TG, Jerome-Majewska LA, Papaioannou VE. Mammary gland, limb and yolk sac defects in mice lacking Tbx3, the gene mutated in human ulnar mammary syndrome. Development. 2003;130(10):2263-73.
68. Luo J, et al. Placental abnormalities in mouse embryos lacking the orphan nuclear receptor ERR-beta. Nature. 1997;388(6644):778-82.
69. Alder O, et al. Ring1B and Suv39h1 delineate distinct chromatin states at bivalent genes during early mouse lineage commitment. Development. 2010;137(15):2483-92.
70. Dahl JA, et al. Histone H3 lysine 27 methylation asymmetry on developmentally-regulated promoters distinguish the first two lineages in mouse preimplantation embryos. PLoS One. 2010;5(2):e9150.
71. Rugg-Gunn PJ, et al. Distinct histone modifications in stem cell lines and tissue lineages from the early mouse embryo. Proc Natl Acad Sci U S A. 2010;107(24):10783-90.
72. Tang F, et al. Tracing the derivation of embryonic stem cells from the inner cell mass by single-cell RNA-Seq analysis. Cell Stem Cell. 2010;6(5):468-78.
73. Kumar RM, et al. Deconstructing transcriptional heterogeneity in pluripotent stem cells. Nature. 2014;516(7529):56-61.
74. Chambers I, et al. Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell. 2003;113(5):643-55.
75. Mitsui K, et al. The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell. 2003;113(5):631-42.
76. Toyooka Y, et al. Identification and characterization of subpopulations in undifferentiated ES cell culture. Development. 2008;135(5):909-18.
77. Canham MA, et al. Functional heterogeneity of embryonic stem cells revealed through translational amplification of an early endodermal transcript. PLoS Biol. 2010;8(5):e1000379.
78. Hayashi K, et al. Dynamic equilibrium and heterogeneity of mouse pluripotent stem cells with distinct functional and epigenetic states. Cell Stem Cell. 2008;3(4):391-401.
79. Falco G, et al. Zscan4: a novel gene expressed exclusively in late 2-cell embryos and embryonic stem cells. Dev Biol. 2007;307(2):539-50.
80. Macfarlan TS, et al. Embryonic stem cell potency fluctuates with endogenous retrovirus activity. Nature. 2012;487(7405):57-63.
81. De Iaco, A., et al., DUX-family transcription factors regulate zygotic genome activation in placental mammals. Nat Genet, 2017.
82. Zalzman M, et al. Zscan4 regulates telomere elongation and genomic stability in ES cells. Nature. 2010;464(7290):858-63.
83. Amano, T., et al., Zscan4 restores the developmental potency of embryonic stem cells. Nat Commun. 2013;4:1966. doi: 10.1038/ncomms2966.
84. Nakai-Futatsugi Y, Niwa H. Zscan4 is activated after telomere shortening in mouse embryonic stem cells. Stem Cell Reports. 2016;6(4):483-95.
85. Plusa B, et al. Distinct sequential cell behaviours direct primitive endoderm formation in the mouse blastocyst. Development. 2008;135(18):3081-91.
86. Chazaud C, et al. Early lineage segregation between epiblast and primitive endoderm in mouse blastocysts through the Grb2-MAPK pathway. Dev Cell. 2006;10(5):615-24.
87. Xenopoulos P, et al. Heterogeneities in Nanog expression drive stable commitment to Pluripotency in the mouse Blastocyst. Cell Rep. 2015;10(9):1508-1520.
88. Guo GJ, et al. Serum-based culture conditions provoke Gene expression variability in mouse embryonic stem cells as revealed by single-cell analysis. Cell Rep. 2016;14(4):956-65.
89. Kunath T, et al. FGF stimulation of the Erk1/2 signalling cascade triggers transition of pluripotent embryonic stem cells from self-renewal to lineage commitment. Development. 2007;134(16):2895-902.
90. Silva J, Smith A. Capturing pluripotency. Cell. 2008;132(4):532-6.
91. Ying QL, et al. The ground state of embryonic stem cell self-renewal. Nature. 2008;453(7194):519-23.
92. Wray J, et al. Inhibition of glycogen synthase kinase-3 alleviates Tcf3 repression of the pluripotency network and increases embryonic stem cell resistance to differentiation. Nat Cell Biol. 2011;13(7):838-45.
93. Merrill BJ. Wnt pathway regulation of embryonic stem cell self-renewal. Cold Spring Harb Perspect Biol. 2012;4(9):a007971.
94. ten Berge D, et al. Embryonic stem cells require Wnt proteins to prevent differentiation to epiblast stem cells. Nat Cell Biol. 2011;13(9):1070-5.
95. Marks H, et al. The transcriptional and epigenomic foundations of ground state pluripotency. Cell. 2012;149(3):590-604.
96. Kolodziejczyk AA, et al. Single cell RNA-sequencing of Pluripotent states unlocks modular transcriptional variation. Cell Stem Cell. 2015;17(4):471-85.
97. Morgani SM, et al. Totipotent embryonic stem cells arise in ground-state culture conditions. Cell Rep. 2013;3(6):1945-57.
98. Schugar RC, Robbins PD, Deasy BM. Small molecules in stem cell self-renewal and differentiation. Gene Ther. 2008;15(2):126-35.
99. Efe JA, Ding S. The evolving biology of small molecules: controlling cell fate and identity. Philos Trans R Soc Lond Ser B Biol Sci. 2011;366(1575):2208-21.
100. Dutta D, et al. Self-renewal versus lineage commitment of embryonic stem cells: protein kinase C signaling shifts the balance. Stem Cells. 2011;29(4):618-28.
101. Ward CM, et al. Efficient germline transmission of mouse embryonic stem cells grown in synthetic serum in the absence of a fibroblast feeder layer. Lab Investig. 2002;82(12):1765-7.
102. Blaschke K, et al. Vitamin C induces Tet-dependent DNA demethylation and a blastocyst-like state in ES cells. Nature. 2013;500(7461):222-6.
103. Papatsenko D, et al. Single-cell analyses of ESCs reveal alternative Pluripotent cell states and molecular mechanisms that control self-renewal. Stem Cell Reports. 2015;5(2):207-20.
104. Ying QL, et al. Conversion of embryonic stem cells into neuroectodermal precursors in adherent monoculture. Nat Biotechnol. 2003;21(2):183-6.
105. Hamazaki T, et al. Aggregation of embryonic stem cells induces Nanog repression and primitive endoderm differentiation. J Cell Sci. 2004;117(Pt 23):5681-6.
106. Price FD, et al. Canonical Wnt signaling induces a primitive endoderm metastable state in mouse embryonic stem cells. Stem Cells. 2013;31(4):752-64.
107. Lancaster MA, Knoblich JA. Organogenesis in a dish: modeling development and disease using organoid technologies. Science. 2014;345(6194):1247125.
108. Turner DA, Baillie-Johnson P, Martinez Arias A. Organoids and the genetically encoded self-assembly of embryonic stem cells. BioEssays. 2016;38(2):181-91.
109. Huang J, et al. Efficient production of mice from embryonic stem cells injected into four- or eight-cell embryos by piezo micromanipulation. Stem Cells. 2008;26(7):1883-90.
110. Poueymirou WT, et al. F0 generation mice fully derived from gene-targeted embryonic stem cells allowing immediate phenotypic analyses. Nat Biotechnol. 2007;25(1):91-9.
111. Saburi S, et al. Developmental fate of single embryonic stem cells microinjected into 8-cell-stage mouse embryos. Differentiation. 1997;62(1):1-11.
112. Lallemand Y, Brulet P. An in situ assessment of the routes and extents of colonisation of the mouse embryo by embryonic stem cells and their descendants. Development. 1990;110(4):1241-8.
113. Eakin GS, et al. Developmental potential and behavior of tetraploid cells in the mouse embryo. Dev Biol. 2005;288(1):150-9.
114. Nagy A, et al. Embryonic stem cells alone are able to support fetal development in the mouse. Development. 1990;110(3):815-21.
115. Nagy A, et al. Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. Proc Natl Acad Sci U S A. 1993;90(18):8424-8.
116. Eggan K, et al. Hybrid vigor, fetal overgrowth, and viability of mice derived by nuclear cloning and tetraploid embryo complementation. Proc Natl Acad Sci U S A. 2001;98(11):6209-14.
117. Hayashi K, Saitou M. Perspectives of germ cell development in vitro in mammals. Anim Sci J. 2014;85(6):617-26.
118. Osorno R, et al. The developmental dismantling of pluripotency is reversed by ectopic Oct4 expression. Development. 2012;139(13):2288-98.
119. Kojima Y, et al. The transcriptional and functional properties of mouse epiblast stem cells resemble the anterior primitive streak. Cell Stem Cell. 2014;14(1):107-20.
120. Najm FJ, et al. Isolation of epiblast stem cells from preimplantation mouse embryos. Cell Stem Cell. 2011;8(3):318-25.
121. Tosolini M, Jouneau A. From naive to primed Pluripotency: in vitro conversion of mouse embryonic stem cells in Epiblast stem cells. Methods Mol Biol. 2016;1341:209-16.
122. Turco MY, et al. Cellular heterogeneity during embryonic stem cell differentiation to epiblast stem cells is revealed by the ShcD/RaLP adaptor protein. Stem Cells. 2012;30(11):2423-36.
123. Camus A, et al. Absence of Nodal signaling promotes precocious neural differentiation in the mouse embryo. Dev Biol. 2006;295(2):743-55.
124. Mesnard D, Guzman-Ayala M, Constam DB. Nodal specifies embryonic visceral endoderm and sustains pluripotent cells in the epiblast before overt axial patterning. Development. 2006;133(13):2497-505.
125. Vallier L, et al. Activin/Nodal signalling maintains pluripotency by controlling Nanog expression. Development. 2009;136(8):1339-49.
126. Feldman B, et al. Requirement of FGF-4 for postimplantation mouse development. Science. 1995;267(5195):246-9.
127. Kurek D, et al. Endogenous WNT signals mediate BMP-induced and spontaneous differentiation of epiblast stem cells and human embryonic stem cells. Stem Cell Reports. 2015;4(1):114-28.
128. Watanabe K, et al. A ROCK inhibitor permits survival of dissociated human embryonic stem cells. Nat Biotechnol. 2007;25(6):681-6.
129. Hunt GC, Singh P, Schwarzbauer JE. Endogenous production of fibronectin is required for self-renewal of cultured mouse embryonic stem cells. Exp Cell Res. 2012;318(15):1820-31.
130. Veluscek G, et al. Jun-mediated changes in cell adhesion contribute to mouse embryonic stem cell exit from ground state Pluripotency. Stem Cells. 2016;34(5):1213-24.
131. Han DW, et al. Epiblast stem cell subpopulations represent mouse embryos of distinct pregastrulation stages. Cell. 2010;143(4):617-27.
132. Gillich A, et al. Epiblast stem cell-based system reveals reprogramming synergy of germline factors. Cell Stem Cell. 2012;10(4):425-39.
133. Jouneau A, et al. Naive and primed murine pluripotent stem cells have distinct miRNA expression profiles. RNA. 2012;18(2):253-64.
134. Hart AH, et al. Identification, cloning and expression analysis of the pluripotency promoting Nanog genes in mouse and human. Dev Dyn. 2004;230(1):187-98.
135. Saiz N, et al. Asynchronous fate decisions by single cells collectively ensure consistent lineage composition in the mouse blastocyst. Nat Commun. 2016;7:13463.
136. Song J, et al. DNA and chromatin modification networks distinguish stem cell Pluripotent ground states. Mol Cell Proteomics. 2012;11(10):1036-47.
137. Orkin SH, Hochedlinger K. Chromatin connections to pluripotency and cellular reprogramming. Cell. 2011;145(6):835-50.
138. Factor DC, et al. Epigenomic comparison reveals activation of "seed" enhancers during transition from naive to primed pluripotency. Cell Stem Cell. 2014;14(6):854-63.
139. Zhang H, et al. MLL1 inhibition reprograms Epiblast stem cells to naive Pluripotency. Cell Stem Cell. 2016;18(4):481-94.
140. Veillard AC, et al. Stable Methylation at promoters distinguishes Epiblast stem cells from embryonic stem cells and the in vivo Epiblasts. Stem Cells Dev. 2014;23(17):2014-29.
141. Iwafuchi-Doi M, et al. Transcriptional regulatory networks in epiblast cells and during anterior neural plate development as modeled in epiblast stem cells. Development. 2012;139(21):3926-37.
142. Tsakiridis A, et al. Distinct Wnt-driven primitive streak-like populations reflect in vivo lineage precursors. Development. 2014;141(6):1209-21.
143. Sun B, et al. Status of genomic imprinting in epigenetically distinct pluripotent stem cells. Stem Cells. 2012;30(2):161-8.
144. Mak W, et al. Reactivation of the paternal X chromosome in early mouse embryos. Science. 2004;303(5658):666-9.
145. Hayashi K, et al. Reconstitution of the mouse germ cell specification pathway in culture by pluripotent stem cells. Cell. 2011;146(4):519-32.
146. Sugimoto M, et al. A simple and robust method for establishing homogeneous mouse epiblast stem cell lines by wnt inhibition. Stem Cell Reports. 2015;4(4):744-57.
147. Hayashi K, Surani MA. Self-renewing epiblast stem cells exhibit continual delineation of germ cells with epigenetic reprogramming in vitro. Development. 2009;136(21):3549-56.
148. Gardner RL, et al. Clonal analysis of X-chromosome inactivation and the origin of the germ line in the mouse embryo. J Embryol Exp Morphol. 1985;88:349-63.
149. Ohtsuka S, Nishikawa-Torikai S, Niwa H. E-cadherin promotes incorporation of mouse epiblast stem cells into normal development. PLoS One. 2012;7(9):e45220.
150. Ohinata Y, et al. A signaling principle for the specification of the germ cell lineage in mice. Cell. 2009;137(3):571-84.
151. Kalkan, T. and A. Smith, Mapping the route from naive pluripotency to lineage specification. Philos Trans R Soc Lond B Biol Sci. 2014 Dec 5;369(1657). pii: 20130540. doi: 10.1098/rstb.2013.0540.
152. Smith A. Formative pluripotency: the executive phase in a developmental continuum. Development. 2017;144(3):365-73.
153. Sancho M, et al. Competitive interactions eliminate unfit embryonic stem cells at the onset of differentiation. Dev Cell. 2013;26(1):19-30.
154. Gouti M, et al. In vitro generation of neuromesodermal progenitors reveals distinct roles for wnt signalling in the specification of spinal cord and paraxial mesoderm identity. PLoS Biol. 2014;12(8):e1001937.
155. Tsukiyama T, Ohinata Y. A modified EpiSC culture condition containing a GSK3 inhibitor can support germline-competent pluripotency in mice. PLoS One. 2014;9(4):e95329.
156. Sumi T, et al. Epiblast ground state is controlled by canonical Wnt/beta-catenin signaling in the postimplantation mouse embryo and epiblast stem cells. PLoS One. 2013;8(5):e63378.
157. Liu P, et al. Requirement for Wnt3 in vertebrate axis formation. Nat Genet. 1999;22(4):361-5.
158. Huelsken J, et al. Requirement for beta-catenin in anterior-posterior axis formation in mice. J Cell Biol. 2000;148(3):567-78.
159. Wu J, et al. An alternative pluripotent state confers interspecies chimaeric competency. Nature. 2015;521(7552):316-21.
160. Joo JY, et al. Establishment of a primed pluripotent epiblast stem cell in FGF4-based conditions. Sci Rep. 2014;4:7477.
161. Chou YF, et al. The growth factor environment defines distinct pluripotent ground states in novel blastocyst-derived stem cells. Cell. 2008;135(3):449-61.
162. Chang KH, Li M. Clonal isolation of an intermediate pluripotent stem cell state. Stem Cells. 2013;31(5):918-27.
163. Rathjen J, et al. Formation of a primitive ectoderm like cell population, EPL cells, from ES cells in response to biologically derived factors. J Cell Sci. 1999;112(Pt 5):601-12.
164. Thomson JA, et al. Embryonic stem cell lines derived from human blastocysts. Science. 1998;282(5391):1145-7.
165. Bongso A, et al. Isolation and culture of inner cell mass cells from human blastocysts. Hum Reprod. 1994;9(11):2110-7.
166. Silva SS, et al. X-chromosome inactivation and epigenetic fluidity in human embryonic stem cells. Proc Natl Acad Sci U S A. 2008;105(12):4820-5.
167. Levenstein ME, et al. Basic fibroblast growth factor support of human embryonic stem cell self-renewal. Stem Cells. 2006;24(3):568-74.
168. Ludwig TE, et al. Derivation of human embryonic stem cells in defined conditions. Nat Biotechnol. 2006;24(2):185-7.
169. Xu C, et al. Basic fibroblast growth factor supports undifferentiated human embryonic stem cell growth without conditioned medium. Stem Cells. 2005;23(3):315-23.
170. Xu RH, et al. Basic FGF and suppression of BMP signaling sustain undifferentiated proliferation of human ES cells. Nat Methods. 2005;2(3):185-90.
171. O'Leary T, et al. Tracking the progression of the human inner cell mass during embryonic stem cell derivation. Nat Biotechnol. 2012;30(3):278-82.
172. Lengner CJ, et al. Derivation of pre-X inactivation human embryonic stem cells under physiological oxygen concentrations. Cell. 2010;141(5):872-83.
173. Hough SR, et al. Single-cell gene expression profiles define self-renewing, pluripotent, and lineage primed states of human pluripotent stem cells. Stem Cell Reports. 2014;2(6):881-95.
174. Hanna J, et al. Human embryonic stem cells with biological and epigenetic characteristics similar to those of mouse ESCs. Proc Natl Acad Sci U S A. 2010;107(20):9222-7.
175. Gafni O, et al. Derivation of novel human ground state naive pluripotent stem cells. Nature. 2013;504(7479):282-6.
176. Theunissen TW, et al. Systematic identification of culture conditions for induction and maintenance of naive human pluripotency. Cell Stem Cell. 2014;15(4):471-87.
177. Ware CB, et al. Derivation of naive human embryonic stem cells. Proc Natl Acad Sci U S A. 2014;111(12):4484-9.
178. Chan YS, et al. Induction of a human pluripotent state with distinct regulatory circuitry that resembles preimplantation epiblast. Cell Stem Cell. 2013;13(6):663-75.
179. Duggal, G., et al., Alternative routes to induce naive Pluripotency in human embryonic stem cells. Stem Cells, 2015. 33(9): 2686-2698.
180. Carter MG, et al. A primitive growth factor, NME7AB, is sufficient to induce stable naive state human Pluripotency; reprogramming in this novel growth factor confers superior differentiation. Stem Cells. 2016;34(4):847-59.
181. Guo G, et al. Naive Pluripotent stem cells derived directly from isolated cells of the human inner cell mass. Stem Cell Reports. 2016;6(4):437-46.
182. Ware CB, et al. Histone deacetylase inhibition elicits an evolutionarily conserved self-renewal program in embryonic stem cells. Cell Stem Cell. 2009;4(4):359-69.
183. Chen H, et al. Reinforcement of STAT3 activity reprogrammes human embryonic stem cells to naive-like pluripotency. Nat Commun. 2015;6:7095.
184. Takashima Y, et al. Resetting transcription factor control circuitry toward ground-state pluripotency in human. Cell. 2014;158(6):1254-69.
185. Amit M, et al. Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Dev Biol. 2000;227(2):271-8.
186. Itskovitz-Eldor J, et al. Differentiation of human embryonic stem cells into embryoid bodies compromising the three embryonic germ layers. Mol Med. 2000;6(2):88-95.
187. Reubinoff BE, et al. Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat Biotechnol. 2000;18(4):399-404.
188. Warrier, S., et al., Direct comparison of distinct naive pluripotent states in human embryonic stem cells. Nat Commun. 2017 Apr 21;8:15055. doi: 10.1038/ncomms15055.
189. Drukker M, et al. Isolation of primitive endoderm, mesoderm, vascular endothelial and trophoblast progenitors from human pluripotent stem cells. Nat Biotechnol. 2012;30(6):531-42.
190. Golos TG, Giakoumopoulos M, Gerami-Naini B. Review: Trophoblast differentiation from human embryonic stem cells. Placenta. 2013;34(Suppl):S56-61.
191. Xu RH, et al. BMP4 initiates human embryonic stem cell differentiation to trophoblast. Nat Biotechnol. 2002;20(12):1261-4.
192. Li Y, Parast MM. BMP4 regulation of human trophoblast development. Int J Dev Biol. 2014;58(2-4):239-46.
193. Bernardo AS, et al. BRACHYURY and CDX2 mediate BMP-induced differentiation of human and mouse pluripotent stem cells into embryonic and extraembryonic lineages. Cell Stem Cell. 2011;9(2):144-55.
194. James D, et al. Contribution of human embryonic stem cells to mouse blastocysts. Dev Biol. 2006;295(1):90-102.
195. Masaki H, et al. Interspecific in vitro assay for the chimera-forming ability of human pluripotent stem cells. Development. 2015;142(18):3222-30.
196. Nakamura T, et al. A developmental coordinate of pluripotency among mice, monkeys and humans. Nature. 2016;537(7618):57-62.
197. Blakeley P, et al. Defining the three cell lineages of the human blastocyst by single-cell RNA-seq. Development. 2015;142(18):3151-65.
198. Huang K, Maruyama T, Fan G. The naive state of human pluripotent stem cells: a synthesis of stem cell and preimplantation embryo transcriptome analyses. Cell Stem Cell. 2014;15(4):410-5.
199. Niakan KK, Eggan K. Analysis of human embryos from zygote to blastocyst reveals distinct gene expression patterns relative to the mouse. Dev Biol. 2013;375(1):54-64.
200. Deglincerti A, et al. Self-organization of the in vitro attached human embryo. Nature. 2016;533(7602):251-4.
201. Shahbazi MN, et al. Self-organization of the human embryo in the absence of maternal tissues. Nat Cell Biol. 2016;18(6):700-8.
202. Moignard V, et al. Decoding the regulatory network of early blood development from single-cell gene expression measurements. Nat Biotechnol. 2015;33(3):269-+.
203. Scialdone A, et al. Resolving early mesoderm diversification through single-cell expression profiling. Nature. 2016;535(7611):289-+.
204. Wen J, et al. Single-cell analysis reveals lineage segregation in early post-implantation mouse embryos. J Biol Chem. 2017;292:9840-854.
205. Guo GJ, et al. Resolution of cell fate decisions revealed by single-cell Gene expression analysis from zygote to Blastocyst. Dev Cell. 2010;18(4):675-85.
206. Ohnishi Y, et al. Cell-to-cell expression variability followed by signal reinforcement progressively segregates early mouse lineages. Nat Cell Biol. 2014;16(1):27-37.
207. Johansson BM, Wiles MV. Evidence for involvement of activin a and bone morphogenetic protein 4 in mammalian mesoderm and hematopoietic development. Mol Cell Biol. 1995;15(1):141-51.